Yumanity Therapeutics, Inc. YMTX
Set alert
1.89 +1.89 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 20.52M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.38
- Beta
- 0.00
- Short ratio
- 1.24
- Inst. own
- 22.57%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 14, 2022
- 50-d avg
- 1.77
- 200-d avg
- 1.59
- 1y target
- 35.00
Financial health
Altman Z-Score
-21.89 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
3 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -1.3×
FY 2024 5y median -1.3× FY 2024
P/S 0.0×
FY 2024 5y median 0.0× FY 2024
P/B -1.9×
FY 2024 5y median -1.9× FY 2024
P/FCF -2.0×
FY 2024 5y median -2.0× FY 2024
EV/EBITDA -1.7×
FY 2024 5y median -1.7× FY 2024
EV/Sales 0.0×
FY 2024 5y median 0.0× FY 2024
FCF Yield -50.6%
FY 2024 5y median -50.6% FY 2024
Profitability
Gross Margin 0.0%
FY 2024 5y median 0.0% FY 2024
Operating Margin 0.0%
FY 2024 5y median 0.0% FY 2024
Net Margin 0.0%
FY 2024 5y median 0.0% FY 2024
ROE 142.4%
FY 2024 5y median 142.4% FY 2024
ROIC 120.4%
FY 2024 5y median 120.4% FY 2024
ROA -1681.3%
FY 2024 5y median -1681.3% FY 2024
Growth (YoY)
Revenue 0.0%
FY 2024 FY 2024
Operating Income 0.0%
FY 2024 FY 2024
EPS (diluted) 0.0%
FY 2024 FY 2024
Free Cash Flow 0.0%
FY 2024 FY 2024
Financial Health
Current Ratio 0.1×
FY 2024 5y median 0.1× FY 2024
Quick Ratio 0.1×
FY 2024 5y median 0.1× FY 2024
Debt / Equity -0.1×
FY 2024 5y median -0.1× FY 2024
Net Debt / EBITDA 0.0×
FY 2024 5y median 0.0× FY 2024
Interest Coverage -98.1×
FY 2024 5y median -98.1× FY 2024
Dividends
Dividend Yield 0.0%
FY 2024 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2024 5y median 0.0% FY 2024
Annual · latest fiscal year ends 2024-12-31